Dr. Kunz on the Impact of Lanreotide’s Approval for Neuroendocrine Tumors OncLive 1:17 9 years ago 804 Далее Скачать
Dr. Kunz on Classifying and Predicting Response in NETs Targeted Oncology 1:24 9 years ago 303 Далее Скачать
Dr. Pavel on the PFS With Lanreotide Autogel in the CLARINET FORTE Trial OncLive 2:11 4 years ago 583 Далее Скачать
Dr. Kunz on Sequencing Agents for the Treatment of Pancreatic NETs Targeted Oncology 1:13 10 years ago 73 Далее Скачать
Dr. Kunz on NET Awareness North American Neuroendocrine Tumor Society 0:36 4 years ago 17 Далее Скачать
The Latest in Systemic Treatments & Considerations for Treatment Sequencing • Dr. Kunz • LACNETS LACNETS 21:49 1 year ago 263 Далее Скачать
FDA-Approved Novel Agent Appears Promising in GEP-NETs Targeted Oncology 1:27 5 years ago 351 Далее Скачать
Pancreatic Cancer Podcast Presented by Dr. Pamela L. Kunz, MD Coby Herd 18:48 8 years ago 22 Далее Скачать
Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future Targeted Oncology 1:01 9 years ago 312 Далее Скачать
Sex differences in patients with neuroendocrine neoplasms North American Neuroendocrine Tumor Society 9:24 3 years ago 168 Далее Скачать
Dr Heloisa Soares Discusses the Roles of Somatostatin Analogs in GEP-NETs AJMCtv 2:03 6 years ago 138 Далее Скачать
